Vontobel Holding Ltd. Sells 8,997 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Vontobel Holding Ltd. lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 40.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 13,365 shares of the company’s stock after selling 8,997 shares during the quarter. Vontobel Holding Ltd.’s holdings in HealthEquity were worth $1,282,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Creative Planning raised its position in shares of HealthEquity by 18.6% in the third quarter. Creative Planning now owns 23,632 shares of the company’s stock valued at $1,934,000 after purchasing an additional 3,706 shares during the period. Raymond James & Associates raised its position in shares of HealthEquity by 1.3% in the third quarter. Raymond James & Associates now owns 151,318 shares of the company’s stock valued at $12,385,000 after purchasing an additional 1,911 shares during the period. Sequoia Financial Advisors LLC raised its position in shares of HealthEquity by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 13,314 shares of the company’s stock valued at $1,090,000 after purchasing an additional 303 shares during the period. Private Advisor Group LLC bought a new position in HealthEquity during the third quarter worth $208,000. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in HealthEquity by 18.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock worth $299,000 after buying an additional 578 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HQY. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. JMP Securities lifted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Barrington Research boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Activity at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is owned by company insiders.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $112.69 on Tuesday. The stock has a market capitalization of $9.77 billion, a P/E ratio of 103.39, a P/E/G ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $102.38 and a two-hundred day moving average price of $91.18.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the firm earned $0.40 earnings per share. Equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.